NHLBI TOPMed: TReating Children to Prevent EXacerbations of Asthma (TREXA)
Anthropometry (1)
- BMI - Body Mass Index calculated from Height and Weight (phv00430342.v1.p1)
Demographics (3)
- age - Subject age (phv00430339.v1.p1)
- SEX - Gender of participant (phv00430340.v1.p1)
- SEX - Sex/gender of subject (phv00570476.v1.p1)
Disease Events (1)
- Affection_Status - Case or Control for asthma (phv00430343.v1.p1)
General Health (1)
- asthma_hospital_Yes12mo - In the last 12 months, has participant been hospitalized because of asthma? (phv00430345.v1.p1)
Medications (1)
- steroids_Yes12mo - In the last 12 months, has participant been prescribed oral steroids (such as prednisone pills or prelone liquid) to help control asthma? (phv00430346.v1.p1)
Race and Ethnicity (1)
- Race - Race of participant (phv00430341.v1.p1)
Respiratory (1)
- delta1 - Bronchodilator Response after 4 puffs of Proventil HFA Albuterol (phv00430347.v1.p1)
Substance Use (1)
- smoke_current - Does participant currently smoke at least 1 cig per day? (phv00430344.v1.p1)
Other (14)
- ANALYTE_TYPE - Analyte Type (phv00430350.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00430349.v1.p1)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body. (phv00430334.v1.p1)
- Funding_Source - Project funding source (phv00430353.v1.p1)
- IS_TUMOR - Tumor status (phv00430351.v1.p1)
- SAMPLE_ID - Sample ID (phv00430348.v1.p1)
- SAMPLE_ID - Sample ID (phv00430337.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00430352.v1.p1)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00430356.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00430338.v1.p1)
- SUBJECT_ID - Subject ID (phv00430333.v1.p1)
- SUBJECT_ID - Subject ID (phv00430336.v1.p1)
- TOPMed_Phase - TOPMed Phase (phv00430354.v1.p1)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00430355.v1.p1)